Find the products and resources you are looking for!
Miltenyi Biotec distribution:
Immunotherapy has proven clinical efficacy and tremendous potential in multiple cancers. However, clinical benefits vary between patients. The research community is therefore intensively investigating how the composition of tumor-infiltrating leukocytes (TILs) contributes to patient stratification and which effects therapeutic interventions have on cell populations within the tumor microenvironment.
Our goal is to support every step of your TIL analysis by providing tools and workflows to maximize the amount and quality of data obtained from limited tumor material.
Copyright © 2020 Miltenyi Biotec and/or its affiliates. All rights reserved.